FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry and represents a pharmaceutical composition for local application on skin for treating inflammation and/or edema in a patient, containing 0.01 % to 10 % w/w. compounds of formula I or a pharmaceutically acceptable salt thereof, wherein the composition is in a topical form and contains a solvent, a co-solvent, a penetration-promoting substance and water.
EFFECT: invention provides penetration into deeper layers of skin and anti-inflammatory action.
41 cl, 6 ex, 7 tbl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS | 2014 |
|
RU2666219C2 |
| THERAPEUTIC USE OF MEDICINAL FORMS OF BERBERINE | 2016 |
|
RU2733743C2 |
| TOPICAL COMPOSITIONS CONTAINING N-ACYL-DIPEPTIDE DERIVATIVES AND GLYCOLIC ACID | 2020 |
|
RU2822387C2 |
| COMPOSITION FOR REDUCING SKIN AGEING DISORDERS, COMPRISING RETINALDEHYDE AND LEONTOPODIUM ALPINUM EXTRACT | 2014 |
|
RU2675702C1 |
| COMPOSITIONS AND METHODS OF SKIN CARE | 2009 |
|
RU2517594C2 |
| NEW HYDANTOIC DERIVATIVES FOR TREATING OBSTRUCTIVE AIRWAY DISEASES | 2005 |
|
RU2386629C2 |
| L-SERINE APPLICABLE AS THERAPEUTIC AGENT FOR PREVENTING AND/OR TREATING INFLAMMATORY SKIN RESPONSES | 2010 |
|
RU2554482C2 |
| AMINOPYRIMIDINYL DERIVATIVES | 2021 |
|
RU2817349C1 |
| METHOD FOR TREATING DISEASES AND CONDITIONS OF THE EYE | 2012 |
|
RU2667645C1 |
| HERBAL EXTRACT OF HEMP WITH LOW CONTENT OF TETRAHYDROCANNABINOL (THC) FOR TREATMENT OF DISEASES | 2008 |
|
RU2599028C2 |
